Kiran Agarwal, MD
Internal Medicine · Monroe, WANPI 1710346135
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,546 of the $3,017 with a category attached, or 84.4%. Stryker accounts for 87.5% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $2,638, more than ten times the $92 reported in 2019. Among internal medicine clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 24 payments — averaging $125.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$3K
- Pfizer$151
- AbbVie$91
- Bayer$40
- Sanofi Pasteur Inc.$23
- Dynavax Technologies Corporation$22
- plus $52 from 3 others
What the payments were for
- Travel & lodging$2,54684%
- Food & beverage$47116%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 5 | $2,638 |
| Pfizer | 8 | $151 |
| AbbVie | 4 | $91 |
| Bayer | 2 | $40 |
| Sanofi Pasteur Inc. | 1 | $23 |
| Dynavax Technologies Corporation | 1 | $22 |
| Organon | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Gilead | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PRO$2,546
How this compares
$3,017 in reported general payments places this provider in the 90th percentile of 2,038 internal medicine providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 27 | $603 |
| Rosuvastatin Calcium | 24 | $232 |
| Levothyroxine Sodium | 36 | $219 |
| Omeprazole | 27 | $208 |
| Fluticasone Propionate | 13 | $182 |
| Lisinopril | 34 | $178 |
| Amlodipine Besylate | 28 | $166 |
| Atorvastatin Calcium | 26 | $149 |
| Metformin Hcl ErMetformin Hcl | 18 | $135 |
| Alendronate Sodium | 13 | $105 |
| Metformin Hcl | 11 | $87 |
| Methocarbamol | 12 | $80 |
| Hydrochlorothiazide | 17 | $74 |
| Losartan Potassium | 16 | $54 |
| Simvastatin | 11 | $52 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Monroe
- Peter ShalitSeattle$1M
- Lawrence LoebBellevue$784K
- Shawna PurcellOlympia$294K
- Scott RamseySeattle$230K
- Michael CairnsSeattle$144K
- Peiqing QianSeattle$117K
- Alan KellySpokane Valley$96K
- Emily EgdaminWenatchee$81K
- Royce MorrisonTacoma$72K
- Safoora ZakaPort Orchard$67K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.